Thus, GEM, S100B, and GZMA might be involved in the muscle dysfunction for COPD patients by ALS-related signaling pathways and might participate in the inflammatory response in COPD by regulating macrophage polarization, and these genes might act as the potential therapeutic targets for muscle atrophy of COPD patients. This evidence concerns the gene S100B and chronic obstructive pulmonary disease.